MJardin Receives Cultivation and Processing License at Second Ontario Facility

Press Release

TORONTO and DENVER, Feb. 19, 2020 MJardin Group, Inc. (“MJardin” or “the Company”) (CSE: MJAR) (OTCQX: MJARF), a leader in premium cannabis production, announced today that one of its indoor cannabis cultivation facilities “GRO”, located in Dunnville, Ontario has received its cultivation and processing license from Health Canada. The facility is a joint venture between MJardin Group (75%) and Grand River Organics (25%).

The 11,000 square foot facility is estimated to produce 1,200 kg of premium flower and 396 kg of trim for a total of 1,596 kg of product per year and is expected to reach full production capacity in Q3 2020. “GRO” houses five compartmentalized flower rooms of equal size. The facility is equipped with optimal HVAC and fertigation systems that will ensure workflow efficiency and consistency in cultivation of product.

“We are pleased to have reached this important milestone and are eager to begin cultivating at this facility,” said Pat Witcher, CEO of MJardin Group. “Our Canadian footprint continues to successfully come online via cultivation and sales of our high THC premium product and we look forward to reaching even more of the market in 2020 with our strategic partners. This is a very exciting time for our group.”

The Company has been awarded four cultivation licenses and two sales licenses in the Canadian portfolio and eagerly anticipates the completion of construction and full roll-out of our Canadian assets.

About MJardin Group

MJardin Group’s mission is to set the standard for successful ownership and management of assets in the cannabis industry. Our Colorado founders spent a decade refining cultivation methodology, collecting and implementing data driven standards and designing state of the art facilities. Today, MJardin owns or manages multiple operations in two US states and three Canadian provinces, supplying the market with premium products. We are committed to our Canadian First Nation joint ventures and all our partnerships across the cannabis supply chain. MJardin is publicly listed on the CSE (MJAR) and the QXOTC (MJARF) with offices in Denver, Colorado and Toronto, Ontario. For more information, please visit www.mjardin.com

The CSE has not in any way passed upon the merits of and has neither approved nor disapproved the contents of this news release.

This news release does not constitute an offer to sell or a solicitation of an offer to sell any of the securities in the United States. The securities have not been and will not be registered under the United States Securities Act of 1933, as amended (the “U.S. Securities Act”) or any state securities laws and may not be offered or sold within the United States or to U.S. Persons unless registered under the U.S. Securities Act and applicable state securities laws or an exemption from such registration is available.

INVESTOR CONTACT:

Ali Mahdavi
Capital Markets & Investor Relations
416-962-3300
Ali.mahdavi@MJardin.com

Pat Witcher
Chief Executive Officer
720-613-4019
Pat.Witcher@Mjardin.com

NT4